Friday, August 15, 2025 8/15/2025

The Role of the Pancreas Microenvironment in Regulating Islet Function and Survival in Type 1 Diabetes

Award Number: R01DK137221
ORGANIZATION: NATIONAL INSTITUTE OF DIABETES & DIGESTIVE & KIDNEY DISEASES
OPDIV: NIH
AWARD CLASS: DISCRETIONARY
AWARD ACTIVITY TYPE: SCIENTIFIC/HEALTH RESEARCH (INCLUDES SURVEYS)
PERIOD OF PERFORMANCE START DATE: 07/01/2024
PERIOD OF PERFORMANCE END DATE: 06/30/2029

Group Awards By:

View Award Description

The Role of the Pancreas Microenvironment in Regulating Islet Function and Survival in Type 1 Diabetes - Project Summary: Type 1 diabetes (T1D) is characterized by the immune-mediated loss of insulin-producing β-cells in the islet. Loss of the peri-islet ECM has been well documented in recently diagnosed patients with T1D and is associated with increased insulitis and β-cell death. In pre-symptomatic T1D, β-cell dysfunction and ER stress occur prior to significant immune cell infiltration. Our preliminary results indicate that cytokine-stressed β- cells express ECM degrading enzymes (including MMPs) that may contribute to loss of the peri-islet ECM prior to the onset of insulitis and may facilitate infiltration of autoreactive immune cells and β-cell death. In the early stages of T1D, islet infiltration correlates with loss of peri-islet laminin-10. Our preliminary data suggests that loss of islet interactions with laminin-10 increases cytokine-induced death and increases the activity of protein kinase C δ (PKCδ), where we have recently identified increases in PKCδ activity as a critical mediator of β-cell death. Additionally, previous studies have shown that islet interactions with laminin increase glucose stimulated insulin secretion (GSIS) via increased expression of glycolytic enzymes and mediate mitochondrial morphology and function. Taken all together, this supports a role for loss of peri-islet laminin-10 in contributing to T1D pathogenesis. We hypothesize that cytokine-stressed β-cells contribute to loss of the peri-islet ECM in early T1D leading to decreases in β-cell function and survival. We propose the following 2 aims: 1) Determine if cytokine-stressed β-cells degrade the peri-islet ECM in early T1D, and 2) Determine if loss of laminin-10 interactions regulates islet survival and function in early T1D. Experiments for both aims will utilize mouse and human islets encapsulated in a novel 3D biomimetic scaffold with laminin-10, as well as human pancreas sections from the nPOD program. Aim 1 will determine if β-cell mediated degradation of the peri-islet ECM precedes the onset of T1D. Aim 2 will determine the molecular mechanisms underlying islet dysfunction and death with loss of peri-islet laminin-10 in T1D. The successful completion of this project will define a new role for the β-cell in degrading the peri-islet ECM in early T1D that contributes to altered islet function and survival. Our results will challenge the current paradigm that β-cells are innocent bystanders in T1D onset and will provide novel therapeutic targets to halt immune infiltration of the islet and improve islet function and survival.


Issue Date FY	Funding FY	Legal Entity Name	Legal Entity Address	Legal Entity City	Legal Entity State	Legal Entity Zip Code	Legal Entity COUNTY	Legal Entity COUNTRY	Assistance Listing	Award Code	Budget Year	Action Date	Action Type	Action Amount

Issue Date FY: 2025 ( Subtotal = $352,618 )
2025	2025	TRUSTEES OF THE COLORADO SCHOOL OF MINES	1500 ILLINOIS ST	GOLDEN	CO	80401	JEFFERSON	USA	Diabetes, Digestive, and Kidney Diseases Extramural Research	000	2	6/18/2025	NON-COMPETING CONTINUATION	$352,618
														Subtotal = $352,618

Issue Date FY: 2024 ( Subtotal = $352,618 )
2024	2024	TRUSTEES OF THE COLORADO SCHOOL OF MINES	1500 ILLINOIS ST	GOLDEN	CO	80401	JEFFERSON	USA	Diabetes, Digestive, and Kidney Diseases Extramural Research	000	1	6/27/2024	NEW	$352,618
														Subtotal = $352,618

Grand Total All Awards = $705,236

Top

All Categories

About

Search

Reports

Data Submission

Award Information

The Role of the Pancreas Microenvironment in Regulating Islet Function and Survival in Type 1 Diabetes

Award Number: R01DK137221

ORGANIZATION: NATIONAL INSTITUTE OF DIABETES & DIGESTIVE & KIDNEY DISEASES

OPDIV: NIH

AWARD CLASS: DISCRETIONARY

AWARD ACTIVITY TYPE: SCIENTIFIC/HEALTH RESEARCH (INCLUDES SURVEYS)

PERIOD OF PERFORMANCE START DATE: 07/01/2024

PERIOD OF PERFORMANCE END DATE: 06/30/2029

Federal Websites

Department of Health & Human Services

HHS Operating Divisions

HHS Staff Divisions

Download A Document Viewer